In addition, AHR high AML samples had lower percentages of total CD56+ NK cells as well as lower mature NK cells defined as lineage negative (CD3-, CD14-, CD20-), CD56dim, or CD94+ CD16+ NK cells (Supplementary Figure 2E, Figure 3C). The gene discussed is FCGR3A; the disease is acute myeloid leukemia.